Abstract submission is closed.
The deadline was September 13, 2019.
We encourage researchers and organizations to submit their data in relation to translating diagnostic- and therapy advances of viral hepatitis into broad applications that accelerate progress toward elimination of viral hepatitis as a public health threat by 2030.
Abstracts should contain the following four components:
A concise statement of the issue under investigation or a hypothesis;
- Material & Methods
The experimental methods used (including the statistical analyses employed);
Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Categories and topics for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
- Monitoring and Testing
- Model for Care - focus on HBV
- Model for Care - focus on HCV
- Strategies to move forward to come to elimination
We are pleased to offer free registration to young professionals with an accepted abstract and a discount on the registration fee for young professionals without an accepted abstract.
Free registrations/discounts are offered to:
- young professionals in training
- young professionals who are younger than 35 and have obtained an MD//PharmD/PhD degree in the last five years
IMPORTANT: free registration is offered to the presenting author of the abstract only.
Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to the submitting author. It is the responsibility of the corresponding/presenting author to inform all co-authors of the status of the abstract. Please notify the Conference Secretariat if you have not received notification by the second week of October. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.
Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.